Veradigm (NASDAQ:MDRX) Trading 14.9% Higher - Still a Buy?

Key Points

• Veradigm shares rose 14.9% intraday to $5.00 from a prior close of $4.35. Trading was minimal at about 819 shares, well below the average daily volume of ~242,356 shares.
• Analyst action: Wall Street Zen upgraded Veradigm to a "hold" on March 7. The stock sits near its 50‑day and 200‑day moving averages (~$4.61 and $4.71) with a market cap of about $517M and a P/E of 23.25.
• Company profile: Veradigm is a healthcare technology firm offering EHR, practice management and revenue cycle management solutions to medical practices, health systems and life sciences organizations.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) was up 14.9% during mid-day trading on Friday . The company traded as high as $5.00 and last traded at $5.00. Approximately 819 shares changed hands during trading, a decline of 100% from the average daily volume of 242,356 shares. The stock had previously closed at $4.35.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Veradigm to a "hold" rating in a report on Saturday, March 7th.

Veradigm Stock Performance

The company's 50-day moving average is $4.61 and its 200-day moving average is $4.71. The firm has a market cap of $517.28 million, a price-to-earnings ratio of 23.25 and a beta of 0.54.

Veradigm Company Profile

Veradigm, Inc NASDAQ: MDRX is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company's offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm's product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.